RecruitingNot ApplicableNCT07543367
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Sponsor
Synchron, Inc.
Enrollment
10 participants
Start Date
Apr 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Eligibility
Min Age: 22 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Stentrode for people with als, als (amyotrophic lateral sclerosis), and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 22 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEStentrode
The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07543367
Related Trials
Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
NCT07823101
Study of Inherited Neurological Disorders
NCT000045682 locations
7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find Non-Invasive Disease Imaging Biomarkers
NCT07818772
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
NCT066499551 location
Digital App for Speech & Health Monitoring
NCT064504181 location